...
首页> 外文期刊>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology >Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [C-11]FLB457 positron emission tomography study
【24h】

Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [C-11]FLB457 positron emission tomography study

机译:前期皮质多巴胺在认知任务期间精神病的临床高风险释放:A [C-11] FLB457正电子发射断层摄影研究

获取原文
获取原文并翻译 | 示例

摘要

Research suggests decreased cortical dopamine is a neural correlate of cognitive deficits in schizophrenia. Evidence of impaired cognitive task-induced cortical dopamine release was demonstrated in patients with psychosis. However, whether cortical dopamine release in response to a cognitive task in clinical high risk for psychosis (CHR) is also impaired, is currently unknown. We aimed to test dopamine release in the dorsolateral prefrontal cortex (DLPFC) and the anterior cingulate cortex (ACC) in antipsychotic-free CHR participants and healthy controls (HC) performing the Wisconsin Card Sorting Task (WCST). Two [C-11]FLB457 PET scans were conducted for 13 CHR and 15 HC while performing the WCST and the sensorimotor control task (SMCT), respectively. A magnetic resonance image was acquired for anatomical delineation. Percentage change in binding potential (Delta BPND) in ACC and DLPFC in WCST were compared with the SMCT between CHR and HC. Mixed model analysis revealed no statistically significant differences in the cognitive task induced Delta BPND in any ROIs. There were no main effect of group (F(1, 26) = 0.348; p = 0.560) or ROI (F(1, 26) = 1.080; p = 0.308) and no significant Group x ROI interaction (F(1, 26) = 0.049; p = 0.826). Our findings suggest no statistically significant difference between CHR and HC in cognitive task-induced cortical dopamine release. This is the first in vivo study to illustrate that the cortical hypodopaminergic state observed in schizophrenia may not be present in its putative high-risk state. (C) 2019 Elsevier B.V. and ECNP. All rights reserved.
机译:研究表明,皮质多巴胺降低是精神分裂症中的认知缺陷的神经相关性。心理学患者证明了认知任务诱导的皮质多巴胺释放受损的证据。但是,皮质多巴胺释放是否响应于心理学症(CHR)的临床高风险中的认知任务也受到损害,目前未知。我们的目的是在抗透视性Chr参与者和健康对照(HC)中进行抗透视前皮质皮质(DLPFC)和前刺型皮质(ACC)的多巴胺释放。执行威斯康星州卡分拣任务(WCST)。在执行WCST和Sensimotor控制任务(SMCT)的同时,在执行WCST和SENSOMOTOR控制任务(SMCT)的同时进行两个[C-11] FLB457 PET扫描。获取磁共振图像以解剖描绘。将WCST中ACC和DLPFC中的结合势(Delta BPND)的百分比变化与CHR和HC之间的SMCT进行比较。混合模型分析显示在任何ROI中的认知任务诱导的Delta BPND没有统计学上显着的差异。组的主要效果(F(1,26)= 0.348; p = 0.560)或rOI(f(1,26)= 1.080; p = 0.308),没有显着的组x投资互动(f(1,26 )= 0.049; p = 0.826)。我们的研究结果表明CHR和HC在认知任务诱导的皮质多巴胺释放中没有统计学显着差异。这是第一个体内研究,以说明在精神分裂症中观察到的皮质低钠氨基能状态可能不会以其推定的高风险状态存在。 (c)2019年Elsevier B.V.和ECNP。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号